综合上述临床药理学研究情况、本品上市后临床应用情况(包括申请人在上市后

The above clinical pharmacology studies, clinical application of the product after the listing (including known and potential safety data applicant actively collected after the listing), and further refinement of the product is listed in the dosing regimen study, further confirming this product application specific diseases, the safety and effectiveness of product-oriented fuller data provided

Combining the above clinical pharmacological research situation, clinical application after the product is listed (including the known and potential safety data collected by the applicant after listing), etc., further optimizes the drug administration plan in the post-market research, further confirms the specific diseases of this product application, and provides more adequate data for the safety and effectiveness of this product.

Based on the above-mentioned clinical pharmacological studies and the clinical application of this product (including the known and potential safety data collected by the applicants on their own initiative) after its listing, the dosage regimen of this product was further optimized in the post-listing study to further confirm the specific diseases of this product and to provide more sufficient data for the safety and effectiveness of this product.<br>